德克斯梅德托米丁抑制胰腺β细胞中葡萄糖刺激的胰岛素分泌
Munenori Kusunoki1, Kiichi Hirota2, Tomohiro Shoji3
1Department of Anesthesiology, Kansai Medical University, Hirakata, Osaka, Japan.
FEBS open bio
|December 20, 2024
概括
德克斯梅德托米丁 (DEX) 在胰腺β细胞中显著抑制葡萄糖刺激胰岛素分泌 (GSIS). 这种效应通过α2-上腺体受体信号传递或受损的胰岛素囊泡外细胞形成,影响葡萄糖代谢.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 在重症监护和术后环境中,最佳血糖控制至关重要,影响患者的治疗结果.
- 包括麻醉剂在内的外科手术期间的药物可以破坏葡萄糖代谢和胰岛素分泌.
- 德克斯梅托米丁 (DEX) 影响葡萄糖代谢和胰岛素释放的确切机制尚未完全理解.
研究的目的:
- 为了研究德克斯梅德托米丁 (DEX) 对葡萄糖刺激胰岛素分泌 (GSIS) 的作用.
- 阐明DEX诱导的胰岛素分泌变化的潜在细胞和分子机制.
主要方法:
- 使用了小鼠和老鼠胰腺β细胞系 (MIN6,INS-1) 和主要胰腺β细胞/小岛.
- 使用酶相关免疫吸收试验 (ELISA) 量化胰岛素分泌.
- 通过补丁来评估细胞活力,细胞毒性和电生理学特性 (例如离子通道功能).
主要成果:
- 临床相关的DEX剂量在所有测试的细胞类型和初级岛屿中显著抑制了GSIS.
- 通过其他胰岛素变异因子刺激的DEX抑制胰岛素分泌.
- DEX没有显著改变氧气消耗,细胞内ATP水平或-3/7活性,也没有影响关键离子通道 (KATP,KV,CaV).
结论:
- 德克斯梅德托米丁 (DEX) 在临床相关度下明显抑制葡萄糖刺激胰岛素分泌 (GSIS).
- 这些发现表明,DEX通过涉及α2-上腺受体信号传递或受损胰岛素囊泡外细胞形成的机制来抑制胰岛素分泌.
- 这项研究提供了关于DEX对胰腺β细胞功能和葡萄糖恒温的影响的见解.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K


